Last reviewed · How we verify

NCT06107621

iCBT for GD and Comorbidities - a Pilot

Status unknown NA Last updated 8 March 2024
What this trial tests

NA trial testing iCBT for Gambling Disorder and psychiatric comorbidities in Gambling Disorder in 30 participants. Status unknown.

Timeline
1 December 2023
Primary endpoint
1 June 2024
1 June 2024

Quick facts

Lead sponsorKarolinska Institutet
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment30
Start date1 December 2023
Primary completion1 June 2024
Estimated completion1 June 2024
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Karolinska Institutet

Who can join

18 and older, any sex, with Gambling Disorder or Comorbidities and Coexisting Conditions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is a pilot study (Total N=30), with at pre, weekly during treatment, post and at three-month follow-up.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Gambling Disorder

Currently open trials in the same condition.

Other Karolinska Institutet trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06107621.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing